2026 NPPES data Medical Oncology Physician NPI 1952359549 MD
Verify on CMS →

MARK KNAPP, MD

Medical Oncology Physician in COLUMBUS, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
768
Medicare Part D claims · 162 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
69%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$15.1K
30 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK KNAPP, MD reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 768 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
768
Part D claims, 2023
69%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK KNAPP, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK KNAPP, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK KNAPP, MD?

Below national average

NPI registry status

Active

Issued 05/05/2006

NPI 1952359549

Primary specialty

Medical Oncology Physician

Niche

3,792 US NPIs in this specialty

Medicare Part D claims

768 11% vs specialty avg

2023 prescription claims

Specialty avg: 689

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Ohio

How Medical Oncology Physician compares to other specialties among Ohio providers

Ohio providers

Medical Oncology Physician share within Ohio

1. Medical Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Medical Oncology Physician share within Ohio

Medicare quality performance — MIPS

MARK KNAPP, MD's 2023 MIPS final score plotted against the Medical Oncology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Medical Oncology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Medical Oncology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK KNAPP, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 3100 PLAZA PROPERTIES BLVD, COLUMBUS, OH, 43219, with a listed phone of (614) 383-6000. NPI 1952359549 was issued on 05/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KNAPP most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 768 prescription claims written by this provider, covering 162 Medicare beneficiaries and totaling roughly $3.8 million in drug spend, split 31% brand-name and 69% generic by claim count, with an opioid prescribing rate of 6.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3100 PLAZA PROPERTIES BLVD
COLUMBUS, OH 43219

Provider Details

NPI 1952359549
Specialty Medical Oncology Physician
Credentials MD
Gender Male
NPI Issued 05/05/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Hospital and facility affiliations

Facilities where MARK KNAPP, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

AMERICAN ONCOLOGY PARTNERS PA
COLUMBUS, OH

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK KNAPP, MD. Source: openpaymentsdata.cms.gov.

Total received

$15.1K

Largest payer

Pharmacosmos Therapeutics Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to MARK KNAPP, MD. To verify MARK KNAPP, MD's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MARK KNAPP, MD — brand share 31.0%
Specialty average (est.)

31% brand-name claims vs 69% generic, on 768 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

768
Total Claims
$3.8M
Total Drug Cost
162
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,079
Total Day Supply
28,453
Brand vs Generic
31% brand / 69% generic
Brand Drug Cost
$3.8M
Generic Drug Cost
$46K
Opioid Claims
53 (6.9% rate)
Antibiotic Claims
17

Patient Demographics

Average Patient Age
75.2 years
Avg HCC Risk Score
2.21
Gender Split
57% female / 43% male
Age Distribution
<65: 16, 65-74: 57, 75-84: 63, 85+: 26

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK KNAPP, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Hydroxyurea
123
Revlimid
Lenalidomide
69
Prochlorperazine Maleate
57
Pomalyst
Pomalidomide
40
Dexamethasone
39
Anastrozole
34
Prednisone
30
Acyclovir
24
Calquence
Acalabrutinib Maleate
23
Duloxetine Hcl
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How MARK KNAPP, MD fits within the Medical Oncology Physician landscape nationally.

3,792
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

MARK KNAPP, MD's 768 claims are above the specialty average of 689.

Nearby Medical Oncology Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as KNAPP.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK KNAPP, MD's specialty?
MARK KNAPP, MD specializes in Medical Oncology Physician and practices in COLUMBUS, Ohio. Credentials: MD.
How much does MARK KNAPP, MD prescribe under Medicare Part D?
In 2023, MARK KNAPP, MD wrote 768 Medicare Part D claims totaling $3.8M in drug costs for 162 beneficiaries.
What is MARK KNAPP, MD's Medicare quality score?
MARK KNAPP, MD has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK KNAPP, MD located?
MARK KNAPP, MD is located at 3100 PLAZA PROPERTIES BLVD, COLUMBUS, OH, 43219. Phone: (614) 383-6000.
What is MARK KNAPP, MD's NPI number?
MARK KNAPP, MD's National Provider Identifier (NPI) is 1952359549, issued on 05/05/2006.
Does MARK KNAPP, MD prescribe more brand-name or generic drugs?
MARK KNAPP, MD's prescribing is 31% brand-name and 69% generic drugs by claim count, with $3.8M in brand drug costs.
Does MARK KNAPP, MD prescribe opioids?
Yes, MARK KNAPP, MD had 53 opioid claims in 2023 with an opioid prescribing rate of 6.9%.
How many Medical Oncology Physician providers are there in the US?
There are 3,792 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does MARK KNAPP, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK KNAPP, MD's most frequently prescribed drugs include Hydroxyurea, Revlimid, Prochlorperazine Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK KNAPP, MD accept Medicare?
MARK KNAPP, MD appears in CMS Medicare data with 768 Part D claims and 162 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK KNAPP, MD's credentials?
MARK KNAPP, MD's NPI is 1952359549 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology